-transparent.png){kind=logo}
Strong evidence has been found for the assumption that NT inhibits its own antidepressive effect at high, but non toxic plasma levels in patients suffering from endogenous depression. Based on three investigations we will recommend an optimal therapeutic plasma range for NT between 50 and 150 ng NT/ml.
Related Publications
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
August 1971,
British medical journal,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
January 1972,
Pharmacology,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
October 1986,
The American journal of psychiatry,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
July 1974,
Clinical pharmacology and therapeutics,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
January 1978,
Communications in psychopharmacology,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
July 1986,
The Keio journal of medicine,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
February 1975,
Proceedings of the Royal Society of Medicine,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
January 1982,
International pharmacopsychiatry,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
June 1970,
Igaku kenkyu. Acta medica,
P Kragh-Søorensen, and
C E Hansen, and
P C Baastrup
March 1982,
The American journal of psychiatry,
